These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12433710)

  • 21. CYP2D6 genetic polymorphisms are associated with susceptibility to pituitary tumors.
    Gomes L; Lemos MC; Paiva I; Ribeiro C; Carvalheiro M; Regateiro FJ
    Acta Med Port; 2005; 18(5):339-43. PubMed ID: 16611538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
    Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic.
    Pardini B; Naccarati A; Novotny J; Smerhovsky Z; Vodickova L; Polakova V; Hanova M; Slyskova J; Tulupova E; Kumar R; Bortlik M; Barale R; Hemminki K; Vodicka P
    Mutat Res; 2008 Feb; 638(1-2):146-53. PubMed ID: 17991492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan.
    Yeh CC; Sung FC; Tang R; Chang-Chieh CR; Hsieh LL
    J Biomed Sci; 2007 Mar; 14(2):183-93. PubMed ID: 17191090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
    Yapijakis C; Serefoglou Z; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E; Vairaktaris E
    Anticancer Res; 2009 Jun; 29(6):2379-86. PubMed ID: 19528505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer.
    Hansen R; Saebø M; Skjelbred CF; Nexø BA; Hagen PC; Bock G; Bowitz Lothe IM; Johnson E; Aase S; Hansteen IL; Vogel U; Kure EH
    Cancer Lett; 2005 Nov; 229(1):85-91. PubMed ID: 15946795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
    Stern MC; Siegmund KD; Corral R; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):609-15. PubMed ID: 15767338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer.
    Cox DG; Pontes C; Guino E; Navarro M; Osorio A; Canzian F; Moreno V;
    Br J Cancer; 2004 Jul; 91(2):339-43. PubMed ID: 15173859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer susceptibility quantitative trait loci in mice as a novel approach to detect low-penetrance variants in humans: a two-stage case-control study.
    Fernández-Rozadilla C; Tarrío R; Clofent J; de Castro L; Brea-Fernández A; Bessa X; Abulí A; Andreu M; Jover R; Xicola R; Llor X; Castells A; Castellví-Bel S; Carracedo A; Ruiz-Ponte C;
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):619-23. PubMed ID: 20142256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human leukocyte antigen region and colorectal cancer risk.
    de Jong MM; Niens M; Nolte IM; te Meerman GJ; van der Graaf WT; Mulder MJ; van der Steege G; Bruinenberg M; Schaapveld M; Sijmons RH; Hofstra RM; de Vries EG; Kleibeuker JH
    Dis Colon Rectum; 2005 Feb; 48(2):303-6. PubMed ID: 15714243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China.
    Zhang Y; Liu B; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
    Cancer Lett; 2009 Mar; 275(1):102-8. PubMed ID: 19036501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer risk.
    Pardini B; Naccarati A; Vodicka P; Kumar R
    Mutagenesis; 2012 Mar; 27(2):161-7. PubMed ID: 22294763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of low-penetrance alleles associated with colon cancer risk].
    Houlston R
    Med Sci (Paris); 2009 Mar; 25 Spec No 1():39-41. PubMed ID: 19361410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General lessons from large-scale studies to identify human cancer predisposition genes.
    Cazier JB; Tomlinson I
    J Pathol; 2010 Jan; 220(2):255-62. PubMed ID: 19927315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms and colorectal tumor risk.
    Houlston RS; Tomlinson IP
    Gastroenterology; 2001 Aug; 121(2):282-301. PubMed ID: 11487538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of NQO1 Pro187Ser polymorphism with the risks for colorectal cancer and colorectal adenoma: a meta-analysis.
    Zhou JY; Shi R; Yu HL; Zheng WL; Ma WL
    Int J Colorectal Dis; 2012 Aug; 27(8):1123-4. PubMed ID: 22116627
    [No Abstract]   [Full Text] [Related]  

  • 39. Common genetic variants (rs4779584 and rs10318) at 15q13.3 contributes to colorectal adenoma and colorectal cancer susceptibility: evidence based on 22 studies.
    Tu L; Yan B; Peng Z
    Mol Genet Genomics; 2015 Jun; 290(3):901-12. PubMed ID: 25475391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chapter 21. Additional polymorphisms and cancer.
    Stubbins MJ; Wolf CR
    IARC Sci Publ; 1999; (148):271-302. PubMed ID: 10493263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.